ResearchMoz

China Research and Intelligence Co., Ltd. (CRI) Market Research Reports

China Research and Intelligence Co., Ltd. (CRI) is engaged in market research in many industrial fields such as pharmaceuticals, automobiles, manufacture and consumer goods. CRI also provide feasibiltiy study, survey, interviews, etc. in China. CRI is always aiming to deliver success to clients.

List of reports from China Research and Intelligence Co., Ltd. (CRI)

Displaying 1 to 30 (of 161 records)
Research Report on Automobile Distribution Industry, 2014-2018
Mar 2014  
China’s auto industry develops rapidly after joining WTO. China became the world's largest auto producer and seller in 2009. In 2013, the production volume of automobiles was 22.1168 million, up by 14.76% YOY, while the sales volume was 21.9841 million which went up by 13.87% YOY. Rapid growth of production and sales of automobiles in China promotes the development of automobile...
$2600
Research Report on Construction Machinery Industry in China, 2014-2018
Mar 2014  
In 2013, China's GDP increased by 7.7% YOY. According to IMF, the growth rate of global economy was merely 3%. China remains one of the fastest growing countries in terms of GDP and resident income in recent years. The GDP per capita was approximately USD 6,600 in 2013, far behind that of developed countries. Therefore, Chinese economy shows great potential for growth.  In 2013,...
$2800
Research Report on Container Manufacturing and Transportation Industry in China, 2014-2018
Mar 2014  
Rapid development of global container transportation promotes the prosperity of container manufacturing industry, which mainly encompasses the customized manufacturing of containers such as dry cargo containers, refrigerated containers and tank containers. The production volume of standard dry cargo containers in China accounts for 90% of the global production volume. China ranks the...
$2600
Research Report on China Shipbuilding Industry, 2014-2018
Mar 2014  
Shipbuilding industry is developing speedily in China. It has greatly contributed to industries such as water transportation, fishery and marine development since China joined WTO. Status of the industry in Chinese economy keeps rising.  The completion volume of ships in China has been increasing rapidly since the 1990s, making China one of the shipbuilding centers in the world....
$2400
Research Report on China Sunroof Industry, 2014-2018
Mar 2014  
Sunroof, as a practical auto accessory for ventilation and interior lighting, is an important consideration for consumers when buying a car. Sunroof is born with vehicles, which once symbolized limousine and luxurious auto configuration. Nowadays many low-price cars are equipped with sunroof due to its popularization.  The automobile industry has developed rapidly since China...
$2400
Research Report on China Waste Incineration for Power Generation Industry, 2014-2018
Mar 2014  
With the development of Chinese economy, upgrading of urbanization and changes of lifestyle, waste output keeps increasing, leading to serious environment pollution. Many cities are faced with garbage disposal problems. China has the most waste output in the world with more than 7 billion tons of untreated municipal solid waste that occupies over 3 billion square meters of land. Out of the 668...
$2000
Research Report on China Dairy Industry, 2014-2018
Mar 2014  
Demand for dairy products keeps increasing as Chinese economy develops and people's lifestyle changes. In 2013 there were more than 600 dairy producers in China. The revenue of main business was approximately CNY 280 billion, up by 14% YOY. The output volume of dairy products was 26.98 million tons, up by 6% YOY. Sales of the product also went up in recent years while the...
$2000
Research Report on China Coke Industry, 2014-2018
Mar 2014  
Coke is widely used in the fields of blast furnace iron-making, cupola iron melting, ferroalloy smelting and non-ferrous metals smelting. As a reducing agent, energy source and carbon agent, coke is also used as a raw material in carbide production, gasification and synthetic chemistry. Statistics shows that over 90% of the global coke production is used in blast furnace iron-making, for which...
$2000
Research Report on China Paper Industry, 2014 - 2018
Mar 2014  
The paper industry in China develops rapidly after China joined WTO. In 1999, total output volume of paper and paperboard in China was only 29 million tons while the number topped 100 million tons in 2010 for the first time. The CAGR of the 11 years was 11.9%. The growth rate began to decline afterward because of the huge base amount. In 2013, the output volume of machine-made paper and...
$2200
Investigation Report on China Valsartan Hydrochlorothiazide Market, 2009 - 2018
Mar 2014  
According to WHO, one-third of the world's adults have hypertension. The global market value of antihypertensive drugs is tens of billion dollars.  Due to the long history of antihypertensive drugs, most hypertensive patients need 2 or more kinds of antihypertensive drugs to reduce the blood pressure to a normal level. There are more than 20 compound preparations of sartan drugs...
$1800
Investigation Report on China Esomeprazole Market, 2009 - 2018
Mar 2014  
Digestive system disease is one of the most frequently occurring diseases. According to statistics from WHO, there are at least 250 million people worldwide suffering from digestive system diseases, especially canker.  Inhibition of gastric acid secretion is the key treatment method for peptic ulcer, duodenal ulcer and gastroesophageal reflux disease. The H+ / K+ ATPase in gastric...
$1800
Investigation Report on China Sildenafil Market, 2009 - 2018
Mar 2014  
There are hundreds of millions of males suffering from sexual dysfunction in the world, of which over 50 million are in China. Statistics indicates that more than 60% of males aged above 35 in China have sexual dysfunction of different degrees. About 50% of the causes of erectile dysfunction are organic, and 30% are psychological while 20% of them are organic and psychological at the same...
$1800
Investigation Report on China Insulin Aspart Market, 2009 - 2018
Mar 2014  
According to IDF (the International Diabetes Federation), incidence of diabetes among adults aged 20-79 in the world was 8.3% in 2013 with more than 380 million patients worldwide.  On December 26, 2001 Novo Nordisk announced that the first insulin analogue insulin aspart (marketed by Novo Nordisk with the trade name "Novorapid") to treat insulin pump was approved by FDA. Insulin...
$1800
Investigation Report on China Insulin Lispro Market, 2009 - 2018
Mar 2014  
According to IDF (the International Diabetes Federation), incidence of diabetes among adults aged 20-79 in the world was 8.3% in 2013 with 382 million patients worldwide. The number of diabetes patients in China was more than 98 million, ranking the first in the world. The rapid growth of diabetes patients is becoming a serious economic and social issue in China and other developing countries....
$1800
Investigation Report on China Pregabalin Market, 2009 - 2018
Mar 2014  
Neuropathic pain is caused by damage or pathological changes of nervous system. Its main features are dull pain, aestus and tingling. About 1% of people worldwide have neuropathic pain. Epileptic seizures are the result of excessive and abnormal cortical nerve cell activity in the brain. It is a group of long-term neurological disorders. As a chronic disease, epilepsy can seriously damage...
$1800
Investigation Report on China Epoetin Alfa Market, 2009 - 2018
Mar 2014  
Epoetin alfa refers to erythropoietin (EPO), a hormone-like substance secreted by kidney and liver that stimulates erythropoiesis. Indications of EOP approved in China are renal anemia, anemia after chemotherapy and surgery perioperative red blood cell mobilization.  The ratio between EPO used in renal dialysis and in chemotherapy is 3:1. Growth rate of EPO used in chemotherapy is...
$1800
Investigation Report on China Aripiprazole Market, 2009 - 2018
Mar 2014  
Schizophrenia is a common mental disorder. Data shows that mental illness has exceeded cardiovascular system, respiratory diseases and malignant tumors and turns into the heaviest social burden. Statistics shows that by the end of 2013 there have been over 10 million schizophrenia patients in China, and the number is still increasing year after year.  Schizophrenia is a chronic...
$1800
Investigation Report on China Olmesartan Market, 2009 - 2018
Mar 2014  
According to statistics from WHO, one-third of the world's adults have high blood pressure. Death toll of this disease equals to half of the total number caused by stroke and heart attack.  Angiotensin II receptor antagonist (ABR) is an important product among various antihypertensive drugs. Developed by Sankyo and Forest Laboratories, olmesartan medoxomil was approved to the...
$1800
Investigation Report on China Adalimumab Market, 2010 - 2018
Mar 2014  
Adalimumab is a TNF (tumor necrosis factor) inhibiting anti-inflammatory drug, the first fully human monoclonal antibody drug approved by the FDA. It was discovered through collaboration between BASF Bioresearch Corporation and Cambridge Antibody Technology in 1993, then further manufactured at BASF Bioresearch Corporation and developed by BASF Knoll (BASF Pharma) and, ultimately, manufactured...
$1800
Investigation Report on China Tiotropium Bromide Market, 2009 - 2018
Mar 2014  
As the air becomes more contaminated, incidence of asthma and chronic obstructive pulmonary diseases also increases. Consequently, more market space is provided for relevant drug manufacturers. Asthma is a common multiple disease mainly caused by inheritance and environment factors. Recurrent attacks of asthma can lead to complications such as chronic obstructive pulmonary disease, emphysema,...
$1800
Investigation Report on China Imatinib Market, 2009 - 2018
Mar 2014  
Incidence of chronic myelogenous leukemia (CML) varies in the world. The global incidence is about 10/1,000,000 while in China it is 4/1,000,000. CML takes up about 20% of leukaemia in China and 95% of chronic leukemia. CML patients vary from the very young to the very old, and the incidence increases as people grow old.  CML treatment went through a long period of development....
$1800
Investigation Report on China Quetiapine Market, 2009 - 2018
Feb 2014  
Schizophrenia is a common mental disorder. As a chronic disease, schizophrenia can lead to recurrent or persistent symptoms in most patients' whole life. As Chinese economy and society develops, life and work here has become increasingly stressful. As a result, recurrence rate of schizophrenia has also increased. Statistics shows that the number of schizophrene in China has exceeded 10 million...
$1800
Investigation Report on China Tacrolimus Market, 2009 - 2018
Feb 2014  
Tacrolimus, also named as "FK506" and "FR-900506", was developed by Fujisawa Pharmaceutical Co., Ltd. (later became Astellas Pharma by merging with Yamanouchi Pharmaceutical Co., Ltd.). In June 1993, it was firstly approved to Japan with the trade name "Prograf". Tacrolimus is an immunosuppressive drug that is used mainly after allogeneic organ transplant to reduce the activity of the...
$1800
Investigation Report on China Enoxaparin Sodium Market, 2009 - 2018
Feb 2014  
Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. It can result in anoxia, the complete deprivation of oxygen and infarction, and even tissue death. Twelve million people worldwide are killed every year by cardiovascular and cerebrovascular diseases such as cerebral thrombosis, cerebral infarction, myocardial...
$1800
Investigation Report on China Pemetrexed Market, 2009 - 2018
Feb 2014  
Pemetrexed, originally developed by Eli Lilly and Company, is a multi-targeted antimetabolite antitumor drug. This product is with huge growth potential in the market.  Approved by FDA in February 2004, pemetrexed is to treat unresectable malignant pleural mesothelioma with cisplatin. It is the first drug approved by FDA to treat the disease. In August 2004 pemetrexed was approved...
$1800
Investigation Report on China Rituximab Market, 2009 - 2018
Feb 2014  
Rituximab (trade names MabThera" by Roche, "Rituxan" by Genetech) is a chimeric monoclonal antibody against the protein CD20 approved in 1997 to treat tumor. It is very effective and shows good tolerance in the treatment of B-cell lymphoma. As people understand more about B-cell and its action mechanism, it is acknowledged that besides B-cell malignancies rituximab can also treat autoimmune...
$1800
Investigation Report on China Telmisartan Market, 2009 - 2018
Feb 2014  
According to statistics from WHO, one-third of the world's adults have high blood pressure. Death toll of this disease equals to half of the total number caused by stroke and heart attack.  Angiotensin II receptor antagonist (ABR) is an important product among various antihypertensive drugs. Telmisartan was firstly developed by Boehringer Ingelheim and approved to the U.S. market...
$1800
Investigation Report on China Insulin Glargine Market, 2009 - 2018
Feb 2014  
With the improvement of people's living standard and changing of lifestyles, as well as deepening of the aging of society, prevalence rate of diabetes keeps rising, making it the third most threatening chronic disease to human health after tumor and cardiovascular disease. Its risk to disable or kill has become a heavy burden on individuals, families, society and governments. ...
$1800
Investigation Report on China Bevacizumab Market, 2009 - 2018
Feb 2014  
Bevacizumab is an important kind of remedy for metastatic colon cancer, which belongs to humanized anti-VEGF monoclonal antibody. Approved by FDA, bevacizumab came into the market in 2004, with the brand name of "Avastin". Its main mechanism is to inhibit the function of a natural protein called vascular endothelial growth factor (VEGF) that stimulates new blood vessel formation through...
$1800
Investigation Report on China Budesonide Market, 2009 - 2018
Feb 2014  
Asthma and allergic rhinitis are both very common diseases in the world today. As the global atmosphere becomes more and more seriously contaminated, incidence of these diseases increases year by year.  Budesonide inhalation suspension (trade name "Pulmicort Respules") developed by Astra Zeneca was approved to market by FDA for asthma treatment in August 2000. It obtained import...
$1800
 
Displaying 1 to 30 (of 161 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData